Anton Parker

1.5k citations

24 papers · 673 indexed · h-index 12

Impact in

Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Genetics 19
- Chronic Lymphocytic Leukemia Research 19
Pathology and Forensic Medicine 12
- Lymphoma Diagnosis and Treatment 12

Co-authors: David Oscier (20 shared papers)Zadie Davis (5 shared papers)Jonathan C. Strefford (7 shared papers)Matthew Rose‐Zerilli (6 shared papers)Andrew Collins (5 shared papers)Helen Parker (6 shared papers)Jenny Orchard (4 shared papers)Anne Gardiner (5 shared papers)
Journals: Blood (8 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (2 papers)Cytometry Part B Clinical Cytometry (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United Kingdom Spain Germany

In The Last Decade

Anton Parker

24 papers receiving 663 citations

Peers

Countries citing papers authored by Anton Parker

Since Specialization

Citations

This map shows the geographic impact of Anton Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Parker more than expected).

Fields of papers citing papers by Anton Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Parker. The network helps show where Anton Parker may publish in the future.

Co-authors

The 25 scholars most cited alongside Anton Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anton Parker Line = papers co-authored together Anton Parker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial Blood ·David Oscier, Matthew Rose‐Zerilli, Nils Winkelmann, David González de Castro, B Moreno Gómez, Jade Forster, Helen Parker, Anton Parker, Anne Gardiner, Andrew Collins, Monica Else, Nicholas C.P. Cross, Daniel Catovsky, Jonathan C. Strefford	2012	150
2	Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis Clinical Cancer Research ·Gordon Strathdee, Tessa L. Holyoake, Alyson Sim, Anton Parker, David Oscier, Junia V. Melo, Stefan Meyer, Tim Eden, Anne M. Dickinson, Joanne C. Mountford, Heather G. Jørgensen, Richard Soutar, Robert Brown	2007	103
3	Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial Journal of Clinical Oncology ·Anna Skowrońska, Anton Parker, Gulshanara Ahmed, Ceri Oldreive, Zadie Davis, Sue Richards, Martin J.S. Dyer, Estella Matutes, David González, A. Malcolm R. Taylor, Paul Moss, Peter Thomas, David Oscier, Tatjana Stanković	2012	77
4	13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia Leukemia ·Helen Parker, Matthew Rose‐Zerilli, Anton Parker, Tracy Chaplin, Rachel Wade, Amy S. Gardiner, Mike Griffiths, Andrew Collins, B D Young, David Oscier, Jonathan C. Strefford	2010	75
5	ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. PubMed ·Martin Corcoran, Anton Parker, Jenny Orchard, Zadie Davis, Michaela Wirtz, Oliver J. Schmitz, David Oscier	2005	66
6	Increased DNA Methylation of ABCB1 , CYP2D6 , and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers The Journal of Pediatrics ·Poppy McLaughlin, Helen Mactier, Cheryl Gillis, Tamas Hickish, Anton Parker, Weijun Liang, M. David Osselton	2017	35
7	High‐throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal‐zone lymphoma British Journal of Haematology ·Vicente Fresquet, Eloy F. Robles, Anton Parker, Javier Martínez‐Useros, Maria Pau Mena, Raquel Malumbres, Xabier Agirre, Susana O. Catarino, David Arteta, Lourdes Osaba, Manuela Mollejo, Jesús María Hernández‐Rivas, Marı́a José Calasanz, Masanori Daibata, Martin J.S. Dyer, Felipe Prósper, E. Vizcarra, Miguel Á. Piris, David Oscier, José A. Martínez-Climent	2012	32
8	ZAP‐70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysis Cytometry Part B Clinical Cytometry ·Giles Best, Rachel Ibbotson, Anton Parker, Zadie Davis, Jennifer Orchard, David Oscier	2006	27
9	ZAP-70 in B cell malignancies Leukemia & lymphoma ·Jenny Orchard, Rachel Ibbotson, Giles Best, Anton Parker, David Oscier	2005	25
10	Methylation markers identify high risk patients inIGHVmutated chronic lymphocytic leukemia Epigenetics ·Laura Irving, Tryfonia Mainou‐Fowler, Anton Parker, Rachel Ibbotson, David Oscier, Gordon Strathdee	2011	17
11	The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity British Journal of Haematology ·Zadie Davis, Francesco Forconi, Anton Parker, Anne Gardiner, Peter Thomas, Daniel Catovsky, Matthew Rose‐Zerilli, Jonathan C. Strefford, David Oscier	2016	15
12	Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia Experimental Hematology ·Marzia Palma, Anton Parker, Mohammad Hojjat‐Farsangi, Jade Forster, Parviz Kokhaei, Lotta Hansson, Anders Österborg, Håkan Mellstedt	2013	13
13	Cross‐talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL Journal of Cellular and Molecular Medicine ·Shilu Amin, Meagan J. Walsh, Caroline Wilson, Anton Parker, David Oscier, Elaine Willmore, Derek A. Mann, Jelena Mann	2011	10
14	ZAP70 in chronic lymphocytic leukaemia The International Journal of Biochemistry & Cell Biology ·Shilu Amin, Anton Parker, Jelena Mann	2007	9
15	Comprehensive next-generation sequencing for clinically actionable mutations from formalin-fixed cancer tissues. Journal of Clinical Oncology ·Jeffrey S. Ross, Doron Lipson, Roman Yelensky, Mirna Jarosz, Anton Parker, Christine E. Sheehan, Frank Juhn, Zac Zwirko, Kristina Brennan, Tabitha Bloom, Stephanie R. Downing, John A. Curran, Maureen Cronin	2011	5
16	13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia. Blood ·Jonathan C. Strefford, Helen Parker, Anton Parker, Hazel M. Robinson, Tracy Chaplin, Xiaohe Chen, David J. Bunyan, Anne Gardiner, Bryan D. Young, David Oscier	2009	3
17	Splenic Marginal Zone Lymphoma: 7q Abnormalities PubMed ·Rachel Ibbotson, Anton Parker, David Oscier	2005	2
18	The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL Blood ·Matthew Rose‐Zerilli, Jade Forster, Helen Parker, Anton Parker, Ana E. Rodriguez, Tracy Chaplin, Anne Gardiner, Andrew Collins, Bryan D. Young, Tatjana Stanković, David Oscier, Jonathan C. Strefford	2012	2
19	ZAP-70 by Flow Cytometry: Comparison of Methodologies, and with IgVH Mutational and ZAP-70 Methylation Status. Blood ·Jenny Orchard, Giles Best, Rachel Ibbotson, Anton Parker, David Oscier	2005	2
20	Epigenetic Regulation of ZAP70 in Chronic Lymphocytic Leukemia. Blood ·Anton Parker, Shilu Amin, Tricia Zwiefelhofer, Ben Gregory, Helen White, Giles Best, Nicholas C.P. Cross, Jelena Mann, Mathias Ehrich, David Oscier	2008	1

About Anton Parker

Anton Parker is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Virology and Hematology, having authored 24 papers that have together received 673 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (12 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Galectins and Cancer Biology (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Cancer Genomics and Diagnostics (2 papers), Viral-associated cancers and disorders (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Genetics (433 citations), Pathology and Forensic Medicine (309 citations), Immunology (236 citations), Hematology (91 citations) and Molecular Biology (281 citations). Anton Parker has collaborated with scholars based in United Kingdom, Spain and Germany. Frequent co-authors include David Oscier, Zadie Davis, Jonathan C. Strefford, Matthew Rose‐Zerilli, Andrew Collins, Helen Parker, Jenny Orchard, Anne Gardiner, Rachel Ibbotson and Jade Forster. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Cytometry Part B Clinical Cytometry and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact